PURE BIOSCIENCE INC COM STK NEW (DE)
PURE
PURE was delisted on the 16th of May, 2013.
1 hedge funds and large institutions have $405K invested in PURE BIOSCIENCE INC COM STK NEW (DE) in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
7% more capital invested
Capital invested by funds: $380K → $405K (+$25K)
0% more funds holding
Funds holding: 1 → 1 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Goldman Capital Management
New York
|
-$44.6K |
PURE Hedge Fund Activity: Q1 2017 in Review
1 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in PURE BIOSCIENCE INC COM STK NEW (DE) (PURE) for Q1 2017, worth a combined $405K — up 6.6% from $380K a quarter earlier.
Fund positioning in PURE was balanced in Q1 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Goldman Capital Management, cutting an estimated $44.6K.
- 1 institutional investor held PURE BIOSCIENCE INC COM STK NEW (DE) (PURE) as of Q1 2017, unchanged from Q4 2016.
- Funds reported $405K of PURE BIOSCIENCE INC COM STK NEW (DE) stock for Q1 2017, up 6.6% quarter-over-quarter.
- 0 funds opened new PURE BIOSCIENCE INC COM STK NEW (DE) positions in Q1 2017 and 0 closed out.
- The largest PURE BIOSCIENCE INC COM STK NEW (DE) seller in Q1 2017 was Goldman Capital Management, an estimated $44.6K sold.
Based on aggregated 13F filings for Q1 2017.